2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-102074
    ERDRP-0519
    		Inhibitor 99.90%
    ERDRP-0519, an orally bioavailable small-molecule Measles virus (MeV) polymerase inhibitor, prevents measles disease in squirrel monkeys (Saimiri sciureus). ERDRP-0519 inhibits morbilliviruses with nanomolar potency..
    ERDRP-0519
  • HY-15615
    TIC10 isomer
    		99.97%
    TIC10 isomer is the isomer of TIC10. TIC10 isomer does not possess the reported biological activity of inducing TRIAL expression.
    TIC10 isomer
  • HY-160410
    Ceramide 3B
    		99.62%
    Ceramide 3B is a ceramide 3 lipid class with aggregation behavior. Ceramide 3B has a variety of physiological functions and can serve as a penetration enhancer and auxiliary emulsifier, playing an important role in barrier function stability.
    Ceramide 3B
  • HY-10499
    PH-064
    		99.88%
    PH-064 (BIM-46187) is an inhibitor of heterotrimeric G-protein complex.
    PH-064
  • HY-102081
    2OH-BNPP1
    		99.65%
    2OH-BNPP1 is an inhibitor of BUB1 kinase, a Ser/Thr kinase, used for the treatment of cancer.
    2OH-BNPP1
  • HY-158009
    SGF29-IN-1
    		Inhibitor ≥98.0%
    SGF29-IN-1 (Compound Cpd_DC60) is a selective inhibitor for Spt-Ada-Gcn5 acetyltransferase (SAGA)–associated factor 29 (SGF29)-Tudor domain. SGF29-IN-1 exhibits activity against leukemia.
    SGF29-IN-1
  • HY-157261
    UNC2383
    		98.68%
    UNC2383 is an oligonucleotide enhancing compound that can enhance effects of antisense oligonucleotides (ASOs), and splice switching oligonucleotides (SSOs).
    UNC2383
  • HY-112132
    Palmitodiolein
    		99.79%
    Palmitodiolein (Triglyceride POO) is a triacylglycerol which is present in vegetable oils.
    Palmitodiolein
  • HY-A0080
    Aminohippurate sodium
    		99.93%
    Aminohippurate sodium is a diagnostic agent useful in medical tests involving the kidney used in the measurement of renal plasma flow.
    Aminohippurate sodium
  • HY-136990
    GLPG0259
    		99.84%
    GLPG0259 is a ATP-competitive inhibitor of MAPK-activated protein kinase 5 (MK5) with oral activity. GLPG0259 reduces inflammation and bone destruction in a mouse model of collagen-induced arthritis. GLPG0259 also inhibited the metastasis of prostate cancer (PCa) cells.
    GLPG0259
  • HY-146695
    S100P-IN-1
    		Inhibitor 99.74%
    S100P-IN-1 (Compound 4) is a S100P inhibitor with an IC50 of 22.7 nM. S100P-IN-1 shows anti-metastatic effects on pancreatic cancer cells.
    S100P-IN-1
  • HY-B1280
    Nikethamide
    		99.87%
    Nikethamide (N,N-Diethylnicotinamide), one of the respiratory central stimulants, has the potential for respiratory failure research.
    Nikethamide
  • HY-112619
    TES-991
    		Inhibitor 99.65%
    TES-991 is a potent and selective human α Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) inhibitor, with an IC50 of 3 nM.
    TES-991
  • HY-141549
    BPK-21
    		99.56%
    BPK-21, an active acrylamide, suppresses T cell activation through blockade of ERCC3 function. BPK-21 specifically targets C342 in the helicase ERCC3.
    BPK-21
  • HY-147319
    RTI-7470-44
    		99.85%
    RTI-7470-44 is a potent, selective and blood-brain barrier (BBB) penetrant human trace amine-associated receptor subtype 1 (hTAAR1) antagonist with an IC50 value of 8.4 nM and a Ki value of 0.3 nM. RTI-7470-44 has moderate metabolic stability, and a favorable preliminary off-target profile. RTI-7470-44 can increase the spontaneous firing rate of mouse ventral tegmental area (VTA) dopaminergic neurons. RTI-7470-44 can be used for researching schizophrenia, agent addiction, and Parkinson’s disease (PD).
    RTI-7470-44
  • HY-148509
    PhosTAC5
    		98.02%
    PhosTAC5 is a phosphorylation targeting chimera (PhosTAC) molecule composed of a linker with fivePEG groups. PhosTAC5 induces dephosphorylation of PDCD4 and FOXO3a.
    PhosTAC5
  • HY-B1730
    Phensuximide
    		99.35%
    Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal.
    Phensuximide
  • HY-112440
    HZX-02-059
    		Activator 99.40%
    HZX-02-059 is a potent methuosis inducer and dual-target PIKfyve/tubulin inhibitor with anticancer activity. Methuosis mainly disrupts the balance of endocytosis and exocytosis, forming a large number of vesicles and inducing cell death. HZX-02-059 also induces cell vacuolization, promotes apoptosis, downregulates the p53 pathway, inhibits PI3K/AKT phosphorylation, and inhibits c-Myc and NF-κB transcription.
    HZX-02-059
  • HY-132182
    HPA-12
    		99.40%
    HPA-12 is an intracellular ceramide transport protein inhibitor.
    HPA-12
  • HY-N1406
    6-Methylcoumarin
    		99.99%
    6-Methylcoumarin is a synthetic fragrance widely used in cosmetics.
    6-Methylcoumarin
Cat. No. Product Name / Synonyms Application Reactivity